American measure rendering full spectrum extracts unfeasible has a long transition period, but already positions Uruguay as a new strategic export alternative

New authorization expands the university's scope in Reblas and reinforces the quality control of plant derivatives in the national market

Regulatory agency bans commercialization and advertising of items from the brands due to lack of sanitary authorization; understand the decision and the companies' positions

Anvisa authorizations for importing cannabidiol in São Paulo increased by 6.2% between January and July 2025, consolidating the state as a leader in requests and reflecting the expanded access through the SUS

Cannabis-based product deliveries are reaching the most remote places in Brazil, revealing the strength of a growing market

In Deusa Cast, a lawyer explains how Customs and Criminal Law act in preventing risks in the importation of cannabis-based products, ensuring safety and agility for companies in the sector

An analysis of the compounds that shape the flavor, aroma, and effects of the plant, focusing on the national scenario

Entrepreneur Fabrício Penafiel considers the inclusion of practical experience of producers in the proposal, with a deadline set for September 30th, a historic opportunity.

Agency determined the prohibition of manufacturing, marketing, and use of mushroom-based supplements produced by Mush Mush Club Ltda.

Draft discussed in a meeting with a YouTube broadcast contains points on THC limit, Sanitary control execution, import and export, destination of the cultivated plant among others

Anvisa informs that, in 2025, the inclusion of data in the SNGPC will be mandatory. Pharmacy professionals have until December 31 to test the tool and clarify doubts

New institute aims to connect companies and authorities to overcome regulatory challenges and promote advancements in the medicinal cannabis ecosystem

Resolution No. 365 of the Federal Council of Biomedicine, which authorizes the prescription of traditional herbal products based on cannabidiol by biomedical professionals, clashes with resolutions of the health agency

Decision from the 2nd Federal Court of Guarulhos determines that authorities do not seize oil, cannabis flowers, and vaporizer used in medical treatment by Argentine patient.

Experts analyze the scenario and highlight that the measure meets Anvisa's expectations for the Brazilian market; Analysis reveals that the new legislation does not represent prohibition, but rather a restructuring of the sector focusing on taxation and pharmaceutical control

Increased demand and bottleneck at the National Narcotics Fund of Colombia cause delays of up to 60 days in certificate issuance and halve exports to Brazil

Deadline set by STJ puts pressure on ministries and Anvisa to conclude pending stages of the action plan

A research by the Federal University of Latin American Integration (UNILA), conducted in partnership with the Santa Cannabis association, will grace the pages of the renowned scientific journal Frontiers in Pharmacology

Change may authorize cultivation by companies under strict control, with a limit of 0.3% THC; measure complies with a decision from the Superior Court of Justice (STJ) related to cultivation regulation.

Court authorization paves the way for personalized and more accessible products for the population